ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors.

被引：0
|
作者：
Ghazaly, Essam Ahmed
Joel, Simon
Gribben, John G.
Mohammad, Tariq
Emiloju, Oluwadunni
Stavraka, Chara
Hopkins, Tom
Gabra, Hani
Wasan, Harpreet
Habib, Nagy A.
Leonard, Robert C. F.
McGuigan, Christopher
Slusarczyk, Magdalena
Blagden, Sarah Patricia
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] Univ London Imperial Coll Sci Technol & Med, NIHR Wellcome Trust Imperial Clin Res Facil, London, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London, England
[4] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2576
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.
    Blagden, Sarah Patricia
    Rizzuto, Ivana
    Stavraka, Chara
    O'Shea, Daniel
    Suppiah, Puvan
    Patel, Markand
    Sukumaran, Ajithkumar
    Loyse, Naomi
    Bharwani, Nishat
    Rockall, Andrea
    Gabra, Hani
    El-Bahrawy, Mona
    Wasan, Harpreet
    Leonard, Robert C. F.
    Habib, Nagy A.
    Gribben, John G.
    Ghazaly, Essam Ahmed
    McGuigan, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors
    Ghazaly, Essam Ahmed
    Rizzuto, Ivana
    Gabra, Hani
    Habib, Nagy A.
    Leonard, Robert C. F.
    Wasan, Harpreet
    McGuigan, Christopher
    Blagden, Sarah Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.
    Blagden, Sarah Patricia
    Rizzuto, Ivana
    Stavraka, Chara
    O'Shea, Daniel
    Suppiah, Puvan
    Patel, Markand
    Loyse, Naomi
    Sukumaran, Ajithkumar
    Bharwani, Nishat
    Rockall, Andrea
    Gabra, Hani
    El-Bahrawy, Mona
    Wasan, Harpreet S.
    Leonard, Robert C. F.
    Habib, Nagy A.
    McGuigan, Christopher
    Gribben, John G.
    Ghazaly, Essam Ahmed
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] First-in-human phase 1 study of DS-1062a in patients with advanced solid tumors.
    Sands, Jacob M.
    Shimizu, Toshio
    Garon, Edward B.
    Greenberg, Jonathan
    Guevara, Ferdinand M.
    Heist, Rebecca Suk
    Kobayashi, Fumiaki
    Noguchi, Yutaka
    Okajima, Daisuke
    Tajima, Naoyuki
    Spira, Alexander I.
    Yamamoto, Noboru
    Lisberg, Aaron Elliott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
    El-Khoueiry, Anthony B.
    Ning, Yan
    Yang, Dongyun
    Cole, Sarah
    Kahn, Michael
    Zoghbi, Marwan
    Berg, Jennifer
    Fujimori, Masamoto
    Inada, Tetsuhi
    Kouji, Hiroyuki
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] A first-in-human phase I study of ER-α36 modifier icaritin in patients with advanced solid tumors.
    Fan, Ying
    Xu, Binghe
    Ding, Xiaoyan
    Ma, Fei
    Wang, Jiayu
    Yuan, Peng
    Luo, Yang
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study
    Blagden, Sarah P.
    Rizzuto, Ivana
    Suppiah, Puvan
    O'Shea, Daniel
    Patel, Markand
    Spiers, Laura
    Sukumaran, Ajithkumar
    Bharwani, Nishat
    Rockall, Andrea
    Gabra, Hani
    El-Bahrawy, Mona
    Wasan, Harpreet
    Leonard, Robert
    Habib, Nagy
    Ghazaly, Essam
    BRITISH JOURNAL OF CANCER, 2018, 119 (07) : 815 - 822
  • [8] First-in-human phase I study of the ALK inhibitor LDK378 in advanced solid tumors.
    Mehra, Ranee
    Camidge, D. Ross
    Sharma, Sunil
    Felip, Enriqueta
    Tan, Daniel Shao-Weng
    Vansteenkiste, Johan F.
    De Pas, Tommaso Martino
    Kim, Dong-Wan
    Santoro, Armando
    Liu, Geoffrey
    Goldwasser, Meredith
    Dai, David
    Radona, Marietta
    Boral, Anthony
    Shaw, Alice Tsang
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] First-in-human study of PM14 in patients with advanced solid tumors.
    Vieito, Maria
    Aix, Santiago Ponce
    Paz-Ares, Luis G.
    Bahleda, Rastilav
    Massard, Christophe
    Agreda, Leyre
    Banus, Eva
    Fernandez, Cristian Marcelo
    Cristoveanu, Elena Y.
    Corral, Gema
    Llanero, Lourdes
    Lubomirov, Rubin
    Kahatt, Carmen Maria
    Fudio, Salvador
    Nieto, Antonio
    Cullell-Young, Martin
    Zeaiter, Ali Hassan
    Oberoi, Honey Kumar
    Garralda, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study
    Sarah P. Blagden
    Ivana Rizzuto
    Puvan Suppiah
    Daniel O’Shea
    Markand Patel
    Laura Spiers
    Ajithkumar Sukumaran
    Nishat Bharwani
    Andrea Rockall
    Hani Gabra
    Mona El-Bahrawy
    Harpreet Wasan
    Robert Leonard
    Nagy Habib
    Essam Ghazaly
    British Journal of Cancer, 2018, 119 : 815 - 822
12345